Xintian Pharmaceutical: An indicative announcement on the adjustment of Xintian debt-for-equity conversion price
Xintian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2024
Xintian Pharmaceutical: Announcement on Cancelling Capital Reduction of Some Repurchased Shares and Notifying Creditors
Xintian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the second quarter of 2024
Xintian Pharmaceutical: An indicative announcement on the resumption of conversion of Xintian Bonds to Shares
GUIYANG XINTIAN PHARMACEUTICAL: Announcement on the indicative price adjustment of the XinTian convertible bond-to-equity swaps.
GUIYANG XINTIAN PHARMACEUTICAL: Announcement regarding the suspension of New Tian Convertible Bonds conversion during the equity distribution period.
GUIYANG XINTIAN PHARMACEUTICAL: Announcement on the indicative price adjustment of the XinTian convertible bond-to-equity swaps.
GUIYANG XINTIAN PHARMACEUTICAL: Announcement on Tracking Rating Results for Convertible Corporate Bonds in 2024.
GUIYANG XINTIAN PHARMACEUTICAL: Guizhou Xintian Pharmaceutical Co., Ltd. and Xintian Convertible Bonds 2024 tracking rating report.
Xintian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the first quarter of 2024
Xintian Pharmaceutical: Announcement on Abnormal Fluctuations in Xintian Bond Transfer Transactions
Xintian Pharmaceutical: Announcement on the resumption of trading of the company's shares, the resumption of trading of convertible corporate bonds, and the conversion of shares
Xintian Pharmaceutical: Announcement on the suspension of trading and share conversion of Xintian Pharmaceutical during the suspension of trading of Xintian Pharmaceutical's stock trading
Xintian Pharmaceutical: Announcement on Not Early Redemption of Xintian Convertible Bonds
Xintian Pharmaceutical: Prompt Announcement on the Possible Satisfaction of Xintian Transfer Bonds to Redemption Requirements
Xintian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the fourth quarter of 2023
Xintian Pharmaceutical: 2023 Interest Payment Announcement on Convertible Corporate Bonds
Xintian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2023
Xintian Pharmaceutical: Notice on not redeeming “Xintian Convertible Bonds” in advance